BDH1 Monoclonal Antibody

This gene encodes a member of the short-chain dehydrogenase/reductase gene family. The encoded protein forms a homotetrameric lipid-requiring enzyme of the mitochondrial membrane and has a specific requirement for phosphatidylcholine for optimal enzymatic activity. The encoded protein catalyzes the interconversion of acetoacetate and (R)-3-hydroxybutyrate, the two major ketone bodies produced during fatty acid catabolism. Alternatively spliced transcript variants encoding the same protein have been described.

Introducing the BDH1 Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of immunology. This meticulously engineered antibody showcases unparalleled specificity and affinity, rendering it an indispensable tool for researchers and clinicians alike.

The BDH1 Monoclonal Antibody boasts an exceptional level of purity, ensuring optimal performance and reproducibility in a wide range of applications. Its robust binding capacity enables precise detection and quantification of target antigens, facilitating accurate and reliable experimental results.

Crafted with utmost precision, the BDH1 Monoclonal Antibody exhibits remarkable stability and longevity, guaranteeing consistent performance over extended periods. Its exceptional resistance to degradation and denaturation ensures the preservation of its functional integrity, thereby maximizing experimental success.

Furthermore, the BDH1 Monoclonal Antibody is meticulously validated through rigorous quality control measures, ensuring its compliance with the highest industry standards. This meticulous validation process guarantees the antibody's reliability, consistency, and reproducibility, instilling confidence in researchers and clinicians alike.

The BDH1 Monoclonal Antibody's versatility is exemplified by its compatibility with various experimental techniques, including immunohistochemistry, flow cytometry, and Western blotting. This adaptability empowers researchers to explore diverse avenues of investigation, facilitating comprehensive and insightful analyses.

In summary, the BDH1 Monoclonal Antibody represents a groundbreaking advancement in the realm of immunology. Its exceptional specificity, stability, and versatility make it an indispensable asset for researchers and clinicians seeking to unravel the complexities of the immune system. Embrace the future of immunological research with the BDH1 Monoclonal Antibody, and unlock a world of possibilities.